Astrazeneca PLC DRC OLD (AZN)

AstraZeneca PLC DRC OLD is a NASDAQ-listed depositary receipt representing common stock of AstraZeneca PLC, a biopharmaceutical company headquartered in Cambridge, United Kingdom. Through its operating business, AstraZeneca is involved in the discovery, development, manufacture, and commercialization of prescription medicines. Its portfolio spans treatments in oncology, cardiovascular, renal and metabolism, respiratory and immunology, vaccines and immune therapies, and rare diseases. The company markets products such as Tagrisso, Imfinzi, Lynparza, Calquence, Farxiga/Forxiga, Brilinta/Brilique, Symbicort, and Beyfortus, among others. AstraZeneca serves physicians and healthcare channels across the UK, the US, Europe, Asia, Africa, and Australasia, and has also entered collaboration agreements with several partners to support research and development initiatives.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Market Cap Free Float / Shares Outstanding Payout Ratio
NASDAQ-AZN
Not available
Not available
Not available
Great
286.6 B
99.5%
52.6%
Valuation • Fair Value

Astrazeneca PLC DRC OLD (NASDAQ-AZN) Fair Value by Valuation Model

No usable valuation estimate is currently available for Astrazeneca PLC DRC OLD (NASDAQ-AZN); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for Astrazeneca PLC DRC OLD (NASDAQ-AZN). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for Astrazeneca PLC DRC OLD (NASDAQ-AZN)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

58.127 B

Current operating scale indicator.

Revenue Forecast

58.659 B

Forward revenue estimate.

EBITDA

20.118 B

Current operating profitability reference.

EBITDA Forecast

19.861 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Astrazeneca PLC DRC OLD (NASDAQ-AZN) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Astrazeneca PLC DRC OLD (NASDAQ-AZN)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Astrazeneca PLC DRC OLD (NASDAQ-AZN). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Astrazeneca PLC DRC OLD (NASDAQ-AZN)

Review the dividend metrics currently supported by the latest data.

Payout Ratio

52.6%

Dividend payout reference.

How to read events and dividends

Upcoming event and dividend data for Astrazeneca PLC DRC OLD (NASDAQ-AZN) is not currently available.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Astrazeneca PLC DRC OLD (NASDAQ-AZN) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Astrazeneca PLC DRC OLD (NASDAQ-AZN) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Astrazeneca PLC DRC OLD (NASDAQ-AZN) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for Astrazeneca PLC DRC OLD (NASDAQ-AZN) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Astrazeneca PLC DRC OLD (NASDAQ-AZN) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Astrazeneca PLC DRC OLD (NASDAQ-AZN) Stock FAQ

Data-supported answers about Astrazeneca PLC DRC OLD (NASDAQ-AZN), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Financial Health
Great
Current financial-health read

A reliable fair value estimate is not currently available for Astrazeneca PLC DRC OLD (NASDAQ-AZN). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for Astrazeneca PLC DRC OLD (NASDAQ-AZN) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The current market capitalization listed for Astrazeneca PLC DRC OLD is 286.6 B.

The ticker symbol for Astrazeneca PLC DRC OLD is NASDAQ-AZN, and the stock is listed on NASDAQ.

Astrazeneca PLC DRC OLD (NASDAQ-AZN) is listed on NASDAQ.

The free float listed for Astrazeneca PLC DRC OLD is 99.5%. Free float helps investors understand how much of the share base is available for public trading.